COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,759 Articles (22,502 medRxiv, 8,257 bioRxiv)

Most recent first Previous |  Page 529: Articles 5281-5290  | Next

Characterizing responsiveness to the COVID-19 pandemic in the United States and Canada using mobility data
Soucy, J.-P. R., Fisman, D. N., MacFadden, D. R., Brown, K. A.
10.1101/2022.11.08.22282050 — Posted: 2022-11-10
Liver injury in hospitalized patients with COVID-19: An International observational cohort study
Tirupakuzhi Vijayaraghavan, B. K., Bishnu, S., Baruch, J., Citarella, B. W., Kartsonaki, C., Meeyai, A., Mohamed, Z., Ohshimo, S., Lefevre, B., Al-Fares, A., Calvache, J. A., Taccone, F. S., Olliaro, P., Merson, L., Adhikari, N. K., ISARIC Clinical Characterisation Group
10.1101/2022.11.06.22282006 — Posted: 2022-11-10
The interface between SARS-CoV-2 and non-communicable diseases (NCDs) in a high HIV/TB burden district level hospital setting, Cape Town, South Africa
Mnguni, A. T., Schietekat, D., Ebrahim, N., Sonday, N., Boliter, N., Schrueder, N., Gabriels, S., Cois, A., Tamuzi, J. L., Tembo, Y., Davies, M.-A., English, R., Nyasulu, P. S.
10.1101/2022.11.08.22282097 — Posted: 2022-11-10
Neurologic sequalae of COVID-19 are determined by immunologic imprinting from previous Coronaviruses.
Spatola, M., Nziza, N., Deng, Y., Jung, W., Yuan, D., Dinoto, A., Bozzetti, S., Chiodega, V., Ferrari, S., Lauffenburger, D. A., Mariotto, S., Alter, G.
10.1101/2022.11.07.22282030 — Posted: 2022-11-10
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated followed by an mRNA vaccine in children aged 5 - 11 years
Wanlapakorn, N., Kanokudom, S., Phowatthanasathian, H., Chansaenroj, J., Suntronwong, N., Assawakosri, S., Yorsaeng, R., Nilyanimit, P., Vichaiwattana, P., Klinfueng, S., Thongmee, T., Aeemjinda, R., Khanarat, N., Srimuan, D., Thatsanatorn, T., Sudhinaraset, N., Poovorawan, Y.
10.1101/2022.11.07.22282028 — Posted: 2022-11-10
Sentiments and Emotions for Vaccination in 2021: An International Comparison Study
Liu, X.-J.
10.1101/2022.11.04.22281946 — Posted: 2022-11-10
Outcome Of Total Surgical Debridement Of Covid Associated Skull base Mucormycosis Based on a New Surgical Staging System: Evidence From A Cohort Study.
Kurup, L. R., Singh, H., Sharma, S., Dehgani-Mobaraki, P., Zaidi, A. K., Janakiram, T. N.
10.1101/2022.11.04.22281828 — Posted: 2022-11-10
SARS-CoV-2 ORF8 limits expression levels of Spike antigen.
Kim, I.-J., Lee, Y.-h., Khalid, M. M., Zhang, Y., Ott, M., Verdin, E.
10.1101/2022.11.09.515752 — Posted: 2022-11-09
Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates.
Marc, A., Marlin, R., Donati, F., Prague, M., Kerioui, M., Herate, C., Alexandre, M., Dereuddre-bosquet, N., Bertrand, J., Contreras, V., Behillil, S., Maisonnasse, P., Van Der Werf, S., Le Grand, R., Guedj, J.
10.1101/2022.11.09.515748 — Posted: 2022-11-09
Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages
Xia, H., Yeung, J., Kalveram, B., Bills, C. J., Chen, J. Y.-C., Kurhade, C., Zou, j., Widen, S. G., Mann, B. R., Kondor, R. J., Davis, T. C., Zhou, B., Wentworth, D. E., Xie, X., Shi, P.-Y.
10.1101/2022.11.08.515725 — Posted: 2022-11-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).